Predicting skeletal complications in metastatic breast cancer raises challenges

Breast Cancer Res Treat. 2010 Oct;123(3):781-3. doi: 10.1007/s10549-010-1104-8. Epub 2010 Aug 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Density Conservation Agents / therapeutic use
  • Bone Neoplasms / complications*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary
  • Breast Neoplasms / pathology*
  • Diphosphonates / therapeutic use
  • Female
  • Fractures, Bone / etiology*
  • Fractures, Bone / prevention & control
  • Humans
  • Imidazoles / therapeutic use
  • Pain / etiology*
  • Pain / prevention & control
  • Risk Assessment
  • Risk Factors
  • Spinal Cord Compression / etiology*
  • Spinal Cord Compression / prevention & control
  • Spinal Fractures / etiology
  • Spinal Fractures / prevention & control
  • Treatment Outcome
  • Zoledronic Acid

Substances

  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid